Cancer care needs innovation that translates into real patient benefit

TLV revises guidelines to price adjustments for high sales value

CHMP issues positive opinion for five new medicines and nine extensions

Palko begins work on Breyanzi recommendation

Sweden lacks a national adult vaccination program

NHTA collaborates with DTU Computerome for Nordic Real-world evidence studies

EFPIA: Invest early in health to save later

US MFN pricing could make Sweden a global price anchor

Denmark weighs allergy medicine reimbursement, with shifts for Grazax

NICE recommends zanidatamab for HER2-positive advanced biliary tract cancer